A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis

NCT04751188 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

11

Enrollment

OTHER_GOV

Sponsor class

Conditions

Primary Biliary Cirrhosis

Interventions

DRUG: Bezafibrate 200 MG Oral Tablet
DRUG: Placebo
DRUG: Ursodeoxycholic Acid

Sponsor

Instituto Mexicano del Seguro Social